110
Participants
Start Date
June 13, 2018
Primary Completion Date
October 21, 2022
Study Completion Date
October 1, 2024
DNA Sequencing, RNA Sequencing
"High-coverage Whole-Exome Sequencing sequencing of DNA samples from ESCC was performed.~RNA expression was analyzed using the NanoString PanCancer Immuno-Oncology 360TM Panel that includes a set of more than 700 genes involved in the main biological pathways of human immunity. These experiments were performed by the Genomics platform of Institut Curie. Total RNAs were used as templates."
Changhai hospital, Shanghai
Wangluowei
OTHER